InsidersTradesSigma
Follow the Accustem Sciences Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Accustem Sciences Inc. has logged 13 reports. Market capitalisation: €3.3m. The latest transaction was reported on 16 June 2025 (Acquisition). Among the most active insiders: CERRONE GABRIELE M. All data is free.
13
Insider Decl.
n/a
Thresholds
€199,523
13 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 June 2025
Declarations13 total
2,000 shares@ US$1.000.9% of flowCommon StockSEC:0001641172-25-015197:0
Canonical exit: 11 Sept 2025 (T+90)
28,205 shares@ US$0.394.8% of flowCommon StockSEC:0001641172-25-015003:0
Canonical exit: 9 Sept 2025 (T+90)
35,000 shares@ US$0.66511.3% of flowCommon StockSEC:0001641172-25-003618:0
Canonical exit: 7 Jul 2025 (T+90)
35,000 shares@ US$0.6511.1% of flowCommon StockSEC:0001641172-25-003222:2
Canonical exit: 6 Jul 2025 (T+90)
100,000 shares@ US$0.44721.7% of flowCommon StockSEC:0001641172-25-003222:0
Canonical exit: 16 Jun 2025 (T+90)
17,802 shares@ US$0.6095.3% of flowCommon StockSEC:0001641172-25-003222:1
Canonical exit: 6 Jul 2025 (T+90)
100,000 shares@ US$0.38119.5% of flowCommon StockSEC:0001493152-25-000211:0
Canonical exit: 31 Mar 2025 (T+90)
5,000 shares@ US$1.403.5% of flowCommon StockSEC:0001493152-23-000064:0
Canonical exit: 30 Mar 2023 (T+90)
3,729 shares@ US$1.422.7% of flowCommon StockSEC:0001493152-22-034396:0
Canonical exit: 2 Mar 2023 (T+90)
24,500 shares@ US$1.0513.2% of flowCommon StockSEC:0001493152-22-033239:0
Canonical exit: 16 Feb 2023 (T+90)
10,000 shares@ US$0.794.1% of flowCommon StockSEC:0001493152-22-020942:0
Canonical exit: 30 Oct 2022 (T+90)
20,000 shares@ US$0.500.18% mcap63.9% of flowCommon StockSEC:0001493152-22-016256:0
Canonical exit: 6 Sept 2022 (T+90)
4,181 shares@ US$1.350.10% mcap36.1% of flowCommon StockSEC:0001493152-22-011318:0
Canonical exit: 24 Jul 2022 (T+90)
13 of 13 declarations
About Accustem Sciences Inc.
Accustem Sciences Inc. is a company focused on developing diagnostic solutions for cancer. It aims to enhance methods for detecting and monitoring oncological diseases.